These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32388832)

  • 1. Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent.
    Koch MW; Mostert J; Greenfield J; Liu WQ; Metz L
    J Neurol; 2020 Sep; 267(9):2619-2624. PubMed ID: 32388832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudocystic inflammatory demyelinating lesions in multiple sclerosis: A clinical, radiological, and pathological description.
    Cluse F; Fenouil T; Vukusic S; Ducray F; Cotton F; Marignier R; Durand-Dubief F
    Mult Scler; 2023 Sep; 29(10):1340-1344. PubMed ID: 37622206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
    Absinta M; Sati P; Masuzzo F; Nair G; Sethi V; Kolb H; Ohayon J; Wu T; Cortese ICM; Reich DS
    JAMA Neurol; 2019 Dec; 76(12):1474-1483. PubMed ID: 31403674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.
    Fernandes L; Allen CM; Williams T; Tallantyre E; Evangelou N; Chataway J; Ford HL;
    Mult Scler Relat Disord; 2021 Oct; 55():103190. PubMed ID: 34365316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the Relevance of the Systematic Use of Gadolinium During the MRI Follow-Up of Multiple Sclerosis Patients Under Natalizumab?
    Bellanger G; Biotti D; Patsoura S; Ciron J; Ferrier M; Gramada R; Meluchova Z; Lerebours F; Catalaa I; Dumas H; Cognard C; Brassat D; Bonneville F
    Clin Neuroradiol; 2020 Sep; 30(3):553-558. PubMed ID: 31143968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between age and inflammatory disease activity on magnetic resonance imaging in relapse onset multiple sclerosis during long-term follow-up.
    Coerver E; Janssens S; Ahmed A; Wessels M; van Kempen Z; Jasperse B; Barkhof F; Koch M; Mostert J; Uitdehaag B; Killestein J; Strijbis E
    Eur J Neurol; 2023 Aug; 30(8):2385-2392. PubMed ID: 37170817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
    Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
    Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
    Zarei F; Ghaedian M; Ghaedian T
    Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
    Kobayashi M; Shimizu Y; Shibata N; Uchiyama S
    J Neurol; 2014 Oct; 261(10):1902-10. PubMed ID: 25034274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.
    Tortorella C; Bellacosa A; Paolicelli D; Fuiani A; Di Monte E; Simone IL; Giaquinto P; Livrea P; Trojano M
    J Neurol Sci; 2005 Dec; 239(1):95-9. PubMed ID: 16209877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
    Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
    Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
    Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
    Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically isolated syndrome and multiple sclerosis in children: a single center study.
    Bektaş G; Özkan MU; Yıldız EP; Uzunhan TA; Sencer S; Aydınlı N; Çalışkan M; Özmen M
    Turk J Pediatr; 2020; 62(2):244-251. PubMed ID: 32419416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance imaging with gadolinium in the acute phase of relapses in multiple sclerosis].
    Ortiz P; Bareno J; Cabrera L; Rueda K; Rovira A
    Rev Neurol; 2017 Mar; 64(6):241-246. PubMed ID: 28272724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
    Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
    J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis.
    Abdoli M; Chakraborty S; MacLean HJ; Freedman MS
    Mult Scler Relat Disord; 2016 Nov; 10():97-102. PubMed ID: 27919508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations].
    Cruz A; Pereira D; Batista S
    Acta Med Port; 2024 Jan; 37(1):53-63. PubMed ID: 38183232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.